Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2024 Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2024 Earnings Call Transcript October 31, 2024

Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $12.46, expectations were $11.69.

Operator: Good morning and welcome to the Regeneron Pharmaceuticals’ Third Quarter 2024 Earnings Conference Call. My name is Shannon and I will be your operator for today’s call. At this time all participants are on a listen-only mode. Later we will conduct a question-and-answer session....